BIGG

Início > Guias GRADE > Resultado da busca

Resultados: 3

Ciltacabtagene autoleucel for treating relapsed or refractory multiple myeloma (terminated appraisal)

England. National Institute for Health and Care Excellence.
NICE is unable to make a recommendation on ciltacabtagene autoleucel (Carvykti) for treating relapsed or refractory multiple myeloma in adults. This is because Janssen withdrew its evidence submission for the appraisal. We will review this decision if the company decides to make a submission....
Mieloma Múltiplo/tratamento farmacológico, Imunoterapia Adotiva
Texto completo

Problema de Salud AUGE N°84: Mieloma Múltiple en personas de 15 años y más
Health Problem AUGE N°84: Multiple Myeloma in people 15 years and older

Chile. Ministerio de Salud. Gobierno de Chile.
El Mieloma Múltiple es un tipo de neoplasia hematológica maligna incurable en la actualidad, que se caracteriza por la afección y multiplicación sin control de células plasmáticas en la médula ósea con su consecuente secreción de una proteína monoclonal y síntomas como anemia, hipercalcemia, f...
Mieloma Múltiplo/cirurgia, Mieloma Múltiplo/tratamento farmacológico, Citogenética, Imunossupressores/uso terapêutico, Transplante Autólogo
Texto completo

Myeloma: diagnosis and management

England. National Institute for Health and Care Excellence.
This guideline covers the diagnosing and managing of myeloma (including smouldering myeloma and primary plasma cell leukaemia) in people aged 16 and over. It aims to improve care for people with myeloma by promoting the most effective tests and treatments for myeloma and its complications....
Mieloma Múltiplo/tratamento farmacológico, Mieloma Múltiplo/complicações, Mieloma Múltiplo/diagnóstico por imagem, Insuficiência Renal Crônica/diagnóstico, Talidomida/uso terapêutico, Dexametasona/uso terapêutico, Procedimentos Clínicos
Texto completo